Metropolitan Life Insurance Co. NY Sells 1,355 Shares of DENTSPLY SIRONA Inc (XRAY)
Metropolitan Life Insurance Co. NY reduced its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 3.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,311 shares of the medical instruments supplier’s stock after selling 1,355 shares during the quarter. Metropolitan Life Insurance Co. NY’s holdings in DENTSPLY SIRONA were worth $1,502,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Piedmont Investment Advisors LLC bought a new stake in shares of DENTSPLY SIRONA during the second quarter worth $117,000. Cornerstone Wealth Management LLC bought a new stake in shares of DENTSPLY SIRONA during the second quarter worth $202,000. Cambridge Investment Research Advisors Inc. bought a new stake in shares of DENTSPLY SIRONA during the second quarter worth $209,000. IBM Retirement Fund grew its holdings in shares of DENTSPLY SIRONA by 49.1% during the first quarter. IBM Retirement Fund now owns 4,955 shares of the medical instruments supplier’s stock worth $249,000 after purchasing an additional 1,631 shares during the last quarter. Finally, Northwest Investment Counselors LLC grew its holdings in shares of DENTSPLY SIRONA by 21.0% during the second quarter. Northwest Investment Counselors LLC now owns 7,582 shares of the medical instruments supplier’s stock worth $332,000 after purchasing an additional 1,318 shares during the last quarter. Hedge funds and other institutional investors own 97.62% of the company’s stock.
Shares of NASDAQ XRAY traded up $0.19 during mid-day trading on Friday, reaching $35.87. 2,241,844 shares of the company’s stock were exchanged, compared to its average volume of 2,663,035. DENTSPLY SIRONA Inc has a twelve month low of $35.30 and a twelve month high of $68.98. The firm has a market cap of $8.39 billion, a P/E ratio of 13.48, a P/E/G ratio of 2.18 and a beta of 1.21. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.69 and a quick ratio of 1.10.
XRAY has been the topic of several recent research reports. ValuEngine upgraded DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a report on Monday, August 13th. Jefferies Financial Group decreased their price target on DENTSPLY SIRONA from $58.00 to $46.00 and set a “buy” rating on the stock in a report on Wednesday, August 8th. BidaskClub cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Thursday, September 27th. Morgan Stanley cut DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $54.00 to $40.00 in a report on Wednesday, August 8th. Finally, Stifel Nicolaus reduced their target price on DENTSPLY SIRONA from $57.00 to $46.00 and set a “buy” rating on the stock in a report on Wednesday, August 8th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $52.18.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: Initial Public Offering (IPO)
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.